Can trazodone (antidepressant medication) lower milk supply in lactating women?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 2, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Can Trazodone Lower Milk Supply?

No, trazodone does not lower milk supply in lactating women. The FDA label explicitly states there are no data on the effect of trazodone on milk production, and available evidence shows only minimal transfer into breast milk without documented effects on lactation 1.

Evidence Supporting Safety for Milk Production

FDA Position on Milk Supply

  • The FDA drug label clearly documents that "there are no data on the effect of trazodone on milk production," meaning no evidence exists that it reduces supply 1
  • Limited postmarketing reports have not identified adverse effects on breastfed children, which would include feeding difficulties from inadequate supply 1

Pharmacokinetic Profile Supports Minimal Impact

  • Trazodone has a very low milk/plasma ratio of 0.142, meaning minimal drug transfer into breast milk 2
  • Infant exposure through breast milk is extremely small: less than 0.005 mg/kg compared to maternal dose of 0.77 mg/kg 2
  • A case study confirmed trazodone concentration in breast milk was only 50.2 ng/mL (with metabolite at 3.2 ng/mL), with no adverse effects observed in the infant at 1-, 3-, and 6-month follow-ups 3

Clinical Recommendations

Trazodone Can Be Used During Breastfeeding

  • Trazodone is compatible with breastfeeding based on its pharmacokinetic profile and clinical experience 4
  • The developmental and health benefits of breastfeeding should be weighed against the mother's clinical need for trazodone, but milk supply concerns should not factor into this decision 1

Contrast with Medications That DO Affect Supply

  • Stimulant medications (e.g., for ADHD) may actually decrease milk supply and should be avoided if supply is a concern 5
  • Clonidine may reduce prolactin secretion and could conceivably reduce milk production in the early postpartum period 6
  • Dopamine agonists would theoretically suppress prolactin and reduce supply, but trazodone does not have this mechanism of action

Common Pitfall to Avoid

  • Do not confuse trazodone with medications that genuinely affect milk supply through prolactin suppression 6, 5
  • If a breastfeeding mother on trazodone experiences low milk supply, investigate other causes (inadequate frequency of feeding/pumping, poor latch, thyroid dysfunction, retained placental fragments) rather than attributing it to the medication 7, 8

Monitoring Recommendations

  • While trazodone does not affect milk supply, monitor the infant for sedation or drowsiness, as trazodone does transfer into breast milk in small amounts 1, 3
  • Ensure the mother takes trazodone before the infant's longest sleep interval to minimize infant exposure 5

References

Research

Excretion of trazodone in breast milk.

British journal of clinical pharmacology, 1986

Research

Trazodone Levels in Maternal Serum, Cord Blood, Breast Milk, and Neonatal Serum.

Breastfeeding medicine : the official journal of the Academy of Breastfeeding Medicine, 2021

Research

Medication Safety in Breastfeeding.

American family physician, 2022

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Metoclopramide for Lactation Enhancement

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Domperidone for Lactation Enhancement in Breastfeeding Mothers

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.